INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
CRISPR Clinical Trials To Follow In 2024 And Beyond
CRISPR therapies are being developed for genetic disorders, cancer, and infectious diseases. Explore which CRISPR clinical trials are worth keeping an eye on this year
-
Precision Oncology Clinical Trials And Statistics 2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.
-
Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)
Explore how this comprehensive approach can offer hope for improved outcomes and quality of life for DMD patients, highlighting global commitment to tackling this complex disorder.
-
Rheumatoid Arthritis – Global Clinical Trial Landscape
While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.
-
Global Prevalence And Clinical Trials Landscape Of DMD
Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.
-
Do ClinOps Professionals Understand The CAR-T Supply Chain?
Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials.
-
How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges
Learn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
FDA’s Updated Guidance On Human Genome Editing: New Implications & Remaining Questions
On Jan. 29, 2024, the FDA released the final version of the guidance document on human gene therapy products incorporating genome editing. This article shares what changed between the draft and now final version of the guidance, and what open questions remain for the industry and scientific community to help resolve.
-
Site Feasibility Tips For Cell And Gene Therapy Clinical Trials
Site feasibility assessment can be challenging. Therefore, it’s essential to have a solid understanding of the regulatory obligations for investigators and sites when it comes to choosing each.
-
Alofisel P3 Cell Therapy Facility
Despite various issues with a client's CQV project, CAI delivered the project on time and significantly contributed to the delivery of the first ATMP facility in Ireland.